Search Results

There are 5452 results for: content related to: A 12-week open-label pilot study of donepezil for cognitive functioning and instrumental activities of daily living in late-life bipolar disorder

  1. Donepezil across the spectrum of Alzheimer's disease: dose optimization and clinical relevance

    Acta Neurologica Scandinavica

    Volume 131, Issue 5, May 2015, Pages: 259–267, J.-H. Lee, S.-K. Jeong, B. C. Kim, K. W. Park and A. Dash

    Version of Record online : 18 FEB 2015, DOI: 10.1111/ane.12386

  2. Steady-State Plasma Concentration of Donepezil Enantiomers and Its Stereoselective Metabolism and Transport In Vitro

    Chirality

    Volume 25, Issue 9, September 2013, Pages: 498–505, Wan Lili, Guo Cheng, Zhou Zhiyong, Yu Qi, Li Yan, Li Dan, Zheng Xueli and Zhong Yuan

    Version of Record online : 25 JUN 2013, DOI: 10.1002/chir.22153

  3. You have free access to this content
    Donepezil for Alzheimer's Disease: Pharmacodynamic, Pharmacokinetic, and Clinical Profiles

    CNS Drug Reviews

    Volume 7, Issue 4, December 2001, Pages: 353–368, Masahiro Shigeta and Akira Homma

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2001.tb00204.x

  4. A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease

    International Journal of Geriatric Psychiatry

    Volume 19, Issue 1, January 2004, Pages: 58–67, Roy W. Jones, Hilkka Soininen, Klaus Hager, Dag Aarsland, Peter Passmore, Anita Murthy, Richard Zhang and Ranbir Bahra

    Version of Record online : 5 JAN 2004, DOI: 10.1002/gps.1038

  5. Donepezil provides positive effects to patients treated with gabapentin for neuropathic pain: an exploratory study

    Acta Anaesthesiologica Scandinavica

    Volume 58, Issue 1, January 2014, Pages: 61–73, A. BASNET, S. BUTLER, P. H. HONORÉ, M. BUTLER, T. E. GORDH, K. KRISTENSEN and O. J. BJERRUM

    Version of Record online : 22 NOV 2013, DOI: 10.1111/aas.12218

  6. You have free access to this content
    Additional donepezil treatment for patients with geriatric depression who exhibit cognitive deficit during treatment for depression

    Psychogeriatrics

    Volume 16, Issue 1, January 2016, Pages: 54–61, Jun Inoue, Ryoichi Hoshino, Hidenori Nojima, Wataru Ishida and Norio Okamoto

    Version of Record online : 27 APR 2015, DOI: 10.1111/psyg.12121

  7. Economic Evaluation of Donepezil for the Treatment of Alzheimer's Disease in Canada

    Journal of the American Geriatrics Society

    Volume 47, Issue 5, May 1999, Pages: 570–578, Bernie J. O'Brien, Ron Goeree, Margaret Hux, Michael Iskedjian, Gordon Blackhouse, Michelle Gagnon and Serge Gauthier

    Version of Record online : 27 APR 2015, DOI: 10.1111/j.1532-5415.1999.tb02572.x

  8. Acute cognitive effects of donepezil in young, healthy volunteers

    Human Psychopharmacology: Clinical and Experimental

    Volume 24, Issue 6, August 2009, Pages: 453–464, Ana LC Zaninotto, Orlando FA Bueno, Márcia Pradella-Hallinan, Sérgio Tufik, Jenny Rusted, Con Stough and Sabine Pompéia

    Version of Record online : 28 JUL 2009, DOI: 10.1002/hup.1044

  9. You have free access to this content
    Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance

    British Journal of Clinical Pharmacology

    Volume 78, Issue 1, July 2014, Pages: 135–144, Muriel Noetzli, Monia Guidi, Karsten Ebbing, Stephan Eyer, Laurence Wilhelm, Agnès Michon, Valérie Thomazic, Ioana Stancu, Abdel-Messieh Alnawaqil, Christophe Bula, Serge Zumbach, Michel Gaillard, Panteleimon Giannakopoulos, Armin von Gunten, Chantal Csajka and Chin B. Eap

    Version of Record online : 20 JUN 2014, DOI: 10.1111/bcp.12325

  10. Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study

    International Journal of Geriatric Psychiatry

    Volume 23, Issue 7, July 2008, Pages: 670–676, Gregory H. Pelton, Oliver L. Harper, Matthias H. Tabert, Harold A. Sackeim, Nikolaos Scarmeas, Steven P. Roose and D. P. Devanand

    Version of Record online : 19 DEC 2007, DOI: 10.1002/gps.1958

  11. Pharmacokinetic and Safety Assessments of Concurrent Administration of Risperidone and Donepezil

    The Journal of Clinical Pharmacology

    Volume 43, Issue 2, February 2003, Pages: 180–186, Qinying Zhao, Charles Xie, Luana Pesco-Koplowitz, Xinwei Jia and Jean-Loup Parier

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270002239827

  12. Benefits of Donepezil on Cognition, Function and Neuropsychiatric Symptoms in Patients with Mild and Moderate Alzheimer's Disease over One Year

    Alzheimer's Disease: Advances in Etiology, Pathogenesis and Therapeutics

    Gunhild Waldemar, Bengt Winblad, Knut Engedal, Hilkka Soininen, Frans Verhey, Anders Wimo, Anna-Lena Wetterholm, Richard Zhang, Anders Haglund, Ponni Subbiah, Pages: 725–738, 2002

    Published Online : 18 APR 2002, DOI: 10.1002/0470846453.ch67

  13. Treatment of Alzheimer's Disease (With or Without Cerebrovascular Disease)

    Evidence-based Dementia Practice

    Lon S. Schneider, Nawab Qizilbash, Mary Sano, Fadi Massoud, Jeffrey Kaye, Jason T. Olin, Knut Laake, Anne Rita Øksengaard, Barry S. Oken, Kristine Yaffe, Kentaro Hashimoto, Jesus López-Arrieta, John C. S. Breitner, Leon Flicker, Kenneth Rockwood, Josẽ Luísrodríquez-Martin, Pages: 467–588, 2008

    Published Online : 14 JAN 2008, DOI: 10.1002/9780470752340.ch34

  14. A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease

    International Journal of Geriatric Psychiatry

    Volume 21, Issue 1, January 2006, Pages: 17–28, A. Takeda, E. Loveman, A. Clegg, J. Kirby, J. Picot, E. Payne and C. Green

    Version of Record online : 2 DEC 2005, DOI: 10.1002/gps.1402

  15. Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial

    International Journal of Geriatric Psychiatry

    Volume 20, Issue 6, June 2005, Pages: 559–569, Howard Feldman, Serge Gauthier, Jane Hecker, Bruno Vellas, Yikang Xu, John R. Ieni and Elias M. Schwam

    Version of Record online : 26 MAY 2005, DOI: 10.1002/gps.1325

  16. You have free access to this content
    Neuroprotection by donepezil against glutamate excitotoxicity involves stimulation of α7 nicotinic receptors and internalization of NMDA receptors

    British Journal of Pharmacology

    Volume 161, Issue 1, September 2010, Pages: 127–139, H Shen, T Kihara, H Hongo, X Wu, WR Kem, S Shimohama, A Akaike, T Niidome and H Sugimoto

    Version of Record online : 25 MAY 2010, DOI: 10.1111/j.1476-5381.2010.00894.x

    Corrected by:

    Erratum

    Vol. 161, Issue 5, 1200, Version of Record online: 8 OCT 2010

  17. The efficacy, safety, and tolerability of donepezil for the treatment of young adults with Down syndrome

    American Journal of Medical Genetics Part A

    Volume 149A, Issue 8, August 2009, Pages: 1641–1654, Priya S. Kishnani, Barbara R. Sommer, Benjamin L. Handen, Benjamin Seltzer, George T. Capone, Gail A. Spiridigliozzi, James H. Heller, Sharon Richardson and Thomas McRae

    Version of Record online : 15 JUL 2009, DOI: 10.1002/ajmg.a.32953

  18. Paper Abstracts

    Journal of the American Geriatrics Society

    Volume 51, Issue s4, April 2003, Pages: 27–237,

    Version of Record online : 4 APR 2003, DOI: 10.1034/j.1600-0889.2000.00001.x

  19. Long-term efficacy of donepezil for relapse of visual hallucinations in patients with dementia with Lewy bodies

    Psychogeriatrics

    Volume 15, Issue 2, June 2015, Pages: 133–137, Katsuyuki Ukai, Hiroshige Fujishiro, Shuji Iritani and Norio Ozaki

    Version of Record online : 16 DEC 2014, DOI: 10.1111/psyg.12089

  20. Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials

    International Journal of Geriatric Psychiatry

    Volume 19, Issue 7, July 2004, Pages: 624–633, Anne Whitehead, Carlos Perdomo, Raymond D. Pratt, Jacqueline Birks, Gordon K. Wilcock and John Grimley Evans

    Version of Record online : 28 JUN 2004, DOI: 10.1002/gps.1133